PREDICTORS OF DISEASE PROGRESSION IN MILD ALZHEIMER'S DISEASE DEMENTIA PATIENTS - RESULTS FROM THE GERAS REAL WORLD COHORT AND EXPEDITION TRIALS

被引：1
|
作者：
Reed, C. [1 ]
Lebrec, J. [2 ]
Andrews, J. S. [3 ]
Bruno, G. [4 ]
Jones, R. W. [5 ]
机构：
[1] Eli Lilly & Co Ltd, Windlesham, Surrey, England
[2] Lilly Deutschland GmbH, Bad Homburg, Germany
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Univ Rome, Rome, Italy
[5] Res Inst Care Older People, Bath, Avon, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.458
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND5
引用
收藏
页码：A425 / A426
页数：2
相关论文
共 50 条
  • [1] Awareness of disease in dementia: preliminary results in patients with mild and moderate Alzheimer's disease
    Dourado, M
    Laks, J
    Rocha, M
    Soares, C
    Leibing, A
    Engelhardt, E
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (01) : 114 - 118
  • [2] Mild cognitive impairment and progression to dementia of Alzheimer's disease
    Quintes Steiner, Ana Beatriz
    Jacinto, Alessandro Ferrari
    De Sa Mayoral, Vania Ferreira
    Dozzi Brucki, Sonia Maria
    Citero, Vanessa De Albuquerque
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 651 - 655
  • [3] Antidepressant Use and Progression of Mild to Moderate Alzheimer's Disease: Results from the European ICTUS Cohort
    Abdeljalil, Anne-Bahia
    de Mauleon, Adelaide
    Baziard, Marion
    Vellas, Bruno
    Lapeyre-Mestre, Maryse
    Soto, Maria
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2021, 22 (02) : 433 - 439
  • [4] Predictors of Disease Progression in Early-Onset Alzheimer's Dementia: A Retrospective Cohort Study
    Velayudhan, Latha
    Baillon, Sarah
    Daby, Laura
    Suntharamoorthy, Pratheep
    Kablan, Alicear
    Tromans, Samuel
    Lindesay, James
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (11) : 1735 - 1739
  • [5] Predictors of progression from mild cognitive impairment to Alzheimer disease
    Rozzini, Luca
    Chilovi, Barbara Vicini
    Trabucchi, Marco
    Padovani, Alessandro
    [J]. NEUROLOGY, 2008, 70 (09) : 735 - 735
  • [6] Predictors of progression from mild cognitive impairment to Alzheimer disease
    Palmer, K.
    Berger, A. K.
    Monastero, R.
    Winblad, B.
    Bachman, L.
    Fratiglioni, L.
    [J]. NEUROLOGY, 2007, 68 (19) : 1596 - 1602
  • [7] Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementia
    Svaldi, Diana Otero
    Higgins, Ixavier A.
    Holdridge, Karen C.
    Yaari, Roy
    Case, Michael
    Bracoud, Luc
    Scott, David
    Shcherbinin, Sergey
    Sims, John R.
    [J]. ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [8] Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions
    Voss, Tiffini
    Kost, James
    Mercer, Swati Pal
    Furtek, Christine
    Randolph, Christopher
    Lines, Christopher
    Egan, Michael F.
    Cummings, Jeffrey L.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (01) : 341 - 348
  • [9] Representativeness of European clinical trial populations in mild Alzheimer's disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
    Reed, Catherine
    Belger, Mark
    Dell'Agnello, Grazia
    Kahle-Wrobleski, Kristin
    Sethuraman, Gopalan
    Hake, Ann
    Raskin, Joel
    Henley, David
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [10] Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
    Catherine Reed
    Mark Belger
    Grazia Dell’Agnello
    Kristin Kahle-Wrobleski
    Gopalan Sethuraman
    Ann Hake
    Joel Raskin
    David Henley
    [J]. Alzheimer's Research & Therapy, 10
12345